To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HERPUD1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
437 supporting clones for gene HERPUD1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC385360 rectum .a 1 to 571 1 to 571   tiling clone,   571/571
(100 %)
0 diff
(100 %id)
TI_43963448   .a 77 to 848 33 to 809       777/809
(96 %)
15 diff
(98.2 %id)
NM_014685.2   .a 77 to 2252 1 to 2176 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 2176/2176
(100 %)
0 diff
(100 %id)
DB003335 breast, tumor tissue .a 356 to 886 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA836854 placenta .a 361 to 891 10 to 540   capped   531/531
(100 %)
0 diff
(100 %id)
TI_44170760   .a 372 to 1253 84 to 966   AAA   883/1040
(84 %)
30 diff
(97.2 %id)
TI_45216485   .a 379 to 1133 122 to 872       751/872
(86 %)
11 diff
(98.8 %id)
TI_45216560   .a 379 to 1207 121 to 948       828/948
(87 %)
14 diff
(98.6 %id)
TI_44342724   .a 379 to 1175 139 to 937       799/943
(84 %)
14 diff
(98.6 %id)
BM147222 leukopheresis .a 381 to 888 1 to 508       508/509
(99 %)
8 diff
(98.5 %id)
BM147346 leukopheresis .a 382 to 881 1 to 500       500/501
(99 %)
4 diff
(99.3 %id)
DA348780 substantia nigra .a 386 to 891 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
DA380168 thalamus .a 386 to 928 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA848185 placenta .a 386 to 961 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA055105 cerebellum .a 387 to 934 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA552375   .a 387 to 963 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
AB034989   .a 388 to 2252 1 to 1865       1865/1865
(100 %)
0 diff
(100 %id)
AK223233 stomach mucosa .a 388 to 2252 1 to 1865   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1865/1865
(100 %)
1 diff
(100.0 %id)
AK291565 placenta .a 388 to 1810 1 to 1423       1423/1423
(100 %)
1 diff
(100.0 %id)
AK292088 synovial membrane tissue from rheumatoidarthritis .a 388 to 1926 1 to 1539       1539/1539
(100 %)
2 diff
(99.9 %id)
DA259238 caudate nucleus .a 388 to 953 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BP222808   .a 388 to 968 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA822430 pericardium .a 388 to 965 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BM772024 stomach .a 388 to 1032 1 to 645       645/645
(100 %)
0 diff
(100 %id)
BM827878 Ascites, stomach .a 388 to 861 1 to 474       474/474
(100 %)
0 diff
(100 %id)
BP341054 stomach mucosa .a 388 to 971 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA013470 adrenal gland .a 389 to 942 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA046587 bladder .a 389 to 878 2 to 491   capped   490/490
(100 %)
0 diff
(100 %id)
DA073408 cerebellum .a 389 to 952 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA078304 cerebellum .a 389 to 819 2 to 432   capped   431/431
(100 %)
0 diff
(100 %id)
DA156908 amygdala .a 389 to 891 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
DA375975 thalamus .a 389 to 956 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA421694 cervix .a 389 to 950 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA561310 heart .a 389 to 964 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA562671 heart .a 389 to 954 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BG757055 B-cells, primary B-cells from tonsils (cell line) .a 389 to 1266 1 to 879       879/881
(99 %)
18 diff
(98.0 %id)
DA636366 Kidney .a 389 to 977 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA822100 pericardium .a 389 to 954 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA826300 pericardium .a 389 to 964 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA844972 placenta .a 389 to 961 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA879292 Prostate .a 389 to 956 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA890898 rectum .a 389 to 934 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA936212 Spleen .a 389 to 985 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DA963385 stomach .a 389 to 943 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA966366 stomach .a 389 to 951 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA988389 synovial membrane tissue from rheumatioidarthritis .a 389 to 950 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB007925 cervix, tumor tissue .a 389 to 952 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB008298 cervix, tumor tissue .a 389 to 843 2 to 456   capped   455/455
(100 %)
0 diff
(100 %id)
DB172306 kidney, tumor tissue .a 389 to 860 2 to 473   capped   472/472
(100 %)
0 diff
(100 %id)
DB197682 trachea .a 389 to 997 2 to 610   capped   609/609
(100 %)
0 diff
(100 %id)
DB208218 trachea .a 389 to 931 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
AF055001 brain .a 391 to 2252 1 to 1862   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1862/1862
(100 %)
1 diff
(100.0 %id)
BG756987 B-cells, primary B-cells from tonsils (cell line) .a 391 to 1262 1 to 861       861/864
(99 %)
17 diff
(98.1 %id)
DA058239 cerebellum .a 392 to 891 2 to 501   capped   500/500
(100 %)
0 diff
(100 %id)
D14695   .a 393 to 2252 1 to 1860   available from KIAA,   1860/1860
(100 %)
3 diff
(99.9 %id)
BQ229599 melanotic melanoma, skin .a 393 to 1195 1 to 809       809/875
(92 %)
17 diff
(98.1 %id)
CR975949 T-Lymphocytes .a 393 to 998 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BF309733 muscle, rhabdomyosarcoma .a 394 to 1164 1 to 770       770/833
(92 %)
15 diff
(98.2 %id)
CD724093 eye, lacrimal gland .a 394 to 916 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BQ923340 epidermoid carcinoma, cell line, lung .a 395 to 1308 1 to 922       922/922
(100 %)
14 diff
(98.5 %id)
TI_57238825   .a 395 to 1182 36 to 822       787/822
(95 %)
9 diff
(99.0 %id)
CV572574 cornea, eye .a 395 to 1004 1 to 610       610/610
(100 %)
0 diff
(100 %id)
TI_59388954   .a 396 to 1199 98 to 899       802/851
(94 %)
15 diff
(98.3 %id)
CT001429 T-Lymphocytes .a 396 to 1091 1 to 696       696/696
(100 %)
0 diff
(100 %id)
AL046131 testis .a 399 to 889 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BC017196 Placenta, choriocarcinoma .a 399 to 2252 2208 to 4061   tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1854/4061
(45 %)
6 diff
(99.9 %id)
BQ961913 epithelioid carcinoma cell line, Pancreas .a 399 to 1282 1 to 893       893/916
(97 %)
14 diff
(98.5 %id)
CR625367 fetal liver .a 400 to 2210 1 to 1811       1811/1811
(100 %)
0 diff
(100 %id)
BX464286 fetal liver, Liver .a 400 to 1304 1 to 904   fully sequenced,   904/904
(100 %)
4 diff
(99.6 %id)
ES310003 scalp interfollicular dermis, skin .a 400 to 986 1 to 585       585/595
(98 %)
9 diff
(98.5 %id)
BI092609 cervix .a 401 to 1128 1 to 728       728/729
(99 %)
4 diff
(99.5 %id)
BM475836 embryonal carcinoma, cell line, testis .a 401 to 1307 1 to 910       910/1055
(86 %)
12 diff
(98.9 %id)
BQ897683 dorsal root ganglia .a 401 to 1216 1 to 820       820/906
(90 %)
10 diff
(98.9 %id)
TI_59386770   .a 401 to 1201 60 to 871       812/854
(95 %)
23 diff
(97.4 %id)
TI_154172729   .a 403 to 1037 89 to 726       638/1105
(57 %)
5 diff
(99.6 %id)
BP352220   .a 404 to 984 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BQ637150 eye, retina .a 407 to 1044 1 to 638       638/641
(99 %)
3 diff
(99.6 %id)
TI_59395381   .a 407 to 1199 93 to 892       800/868
(92 %)
18 diff
(98.0 %id)
DB483851 hippocampus .a 409 to 900 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BQ937531 epidermoid carcinoma, cell line, lung .a 411 to 1244 1 to 851       851/942
(90 %)
26 diff
(97.3 %id)
CR980657 T-Lymphocytes .a 411 to 1086 1 to 676       676/676
(100 %)
0 diff
(100 %id)
BE794901 lung, small cell carcinoma .a 412 to 1239 1 to 819       819/879
(93 %)
9 diff
(99.0 %id)
CA394167 eye, RPE/choroid .a 413 to 882 1 to 470       470/470
(100 %)
0 diff
(100 %id)
BE733081 choriocarcinoma, placenta .a 413 to 1245 1 to 829       829/986
(84 %)
30 diff
(97.0 %id)
TI_57240983   .a 413 to 1277 32 to 903       872/903
(96 %)
23 diff
(97.5 %id)
BE407936 choriocarcinoma, placenta .a 415 to 1078 1 to 662       662/797
(83 %)
4 diff
(99.5 %id)
BE734205 choriocarcinoma, placenta .a 415 to 1226 1 to 813       813/1027
(79 %)
18 diff
(98.3 %id)
CN481745 eye .a 416 to 1002 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BM722649 eye, fetal eye .a 417 to 981 1 to 565     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 565/565
(100 %)
0 diff
(100 %id)
BE730770 choriocarcinoma, placenta .a 420 to 1234 1 to 810       810/1140
(71 %)
29 diff
(97.5 %id)
CB216553 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 424 to 945 1 to 522       522/522
(100 %)
0 diff
(100 %id)
TI_154185937   .a 425 to 1255 121 to 938       818/972
(84 %)
25 diff
(97.5 %id)
DB055694 testis .a 426 to 972 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BQ943111 large cell carcinoma, lung .a 427 to 1347 1 to 927       927/930
(99 %)
21 diff
(97.8 %id)
BQ939568 large cell carcinoma, lung .a 427 to 1362 1 to 944       944/948
(99 %)
21 diff
(97.8 %id)
CR979470 T-Lymphocytes .a 428 to 1179 1 to 752       752/752
(100 %)
0 diff
(100 %id)
AW239338 lung, cell line .a 453 to 1072 1 to 620       620/621
(99 %)
1 diff
(99.9 %id)
BP211981 cerebrum .a 468 to 1051 1 to 584       584/584
(100 %)
0 diff
(100 %id)
TI_1948126522   .a 485 to 1039 131 to 688       558/1425
(39 %)
31 diff
(97.9 %id)
CR457116   .a 486 to 1657 1 to 1172       1172/1176
(99 %)
1 diff
(100.0 %id)
CV025726 mixed .a 486 to 1134 1 to 650       650/652
(99 %)
7 diff
(99.0 %id)
BU179825 melanotic melanoma, cell line, skin .a 551 to 1275 1 to 727       727/956
(76 %)
9 diff
(99.1 %id)
DA008975 adrenal gland .a 563 to 1123 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BQ682023 melanotic melanoma, cell line, skin .a 639 to 1009 1 to 371       371/371
(100 %)
0 diff
(100 %id)
BQ684466 melanotic melanoma, cell line, skin .a 639 to 1507 1 to 883       881/960
(91 %)
26 diff
(97.3 %id)
BQ683531 melanotic melanoma, cell line, skin .a 639 to 932 1 to 294       294/294
(100 %)
0 diff
(100 %id)
BU190851 melanotic melanoma, cell line, skin .a 639 to 1493 1 to 869       869/951
(91 %)
16 diff
(98.4 %id)
BX464285 fetal liver, Liver .a 1289 to 2210 922 to 1   fully sequenced,   922/922
(100 %)
0 diff
(100 %id)
BM679138 eye, fetal eye .a 1535 to 2252 736 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 718/718
(100 %)
0 diff
(100 %id)
TI_59395382   .a 1701 to 2173 491 to 2       490/496
(98 %)
0 diff
(100 %id)
NM_001010989.1   .b 1 to 2173 1 to 2173 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 2173/2173
(100 %)
0 diff
(100 %id)
BP274100 Kidney .b 312 to 872 1 to 562       562/580
(96 %)
13 diff
(97.8 %id)
DA968571 stomach .b 312 to 873 2 to 564   tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
DA129882 alzheimer cortex .b 313 to 857 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA470074   .b 313 to 884 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA825041 pericardium .b 313 to 881 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
AU135027 placenta .b 313 to 1086 2 to 785   capped   784/859
(91 %)
17 diff
(98.1 %id)
DA875688 Prostate .b 313 to 870 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA937789 Spleen .b 313 to 833 2 to 521   capped   520/520
(100 %)
4 diff
(99.3 %id)
DA938595 Spleen .b 313 to 915 2 to 604   capped   603/603
(100 %)
3 diff
(99.6 %id)
DA962275 stomach .b 313 to 1160 2 to 837   tiling clone, capped   836/842
(99 %)
36 diff
(95.8 %id)
CN386603 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 318 to 798 1 to 481       481/481
(100 %)
3 diff
(99.4 %id)
BE397787 Burkitt lymphoma, lymph .b 318 to 1020 27 to 727       701/728
(96 %)
14 diff
(98.1 %id)
TI_57238898   .b 324 to 1156 35 to 863   AAA   829/876
(94 %)
15 diff
(98.3 %id)
BI915919 brain .b 325 to 1176 1 to 848       848/849
(99 %)
12 diff
(98.6 %id)
AL557129 T cells (Jurkat cell line), T cells from T cell leukemia .b 329 to 1179 1 to 846   fully sequenced,   846/846
(100 %)
6 diff
(99.3 %id)
DB027239 testis .b 332 to 786 2 to 457   capped   456/456
(100 %)
1 diff
(99.8 %id)
BE731824 choriocarcinoma, placenta .b 339 to 1128 1 to 785       785/1087
(72 %)
12 diff
(98.9 %id)
BE731083 choriocarcinoma, placenta .b 340 to 1097 1 to 751       751/754
(99 %)
19 diff
(97.5 %id)
BE900486 choriocarcinoma, placenta .b 340 to 1046 1 to 702       702/704
(99 %)
6 diff
(99.2 %id)
BE548743 cervical carcinoma cell line, cervix .b 342 to 990 1 to 653       653/657
(99 %)
7 diff
(99.0 %id)
AF055003 brain .b 512 to 2173 1 to 1662   tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1662/1662
(100 %)
0 diff
(100 %id)
R13237 whole brain .b 514 to 828 1 to 326     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 326/349
(93 %)
20 diff
(94.3 %id)
R14436 whole brain .b 514 to 873 1 to 370     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 370/398
(92 %)
17 diff
(95.8 %id)
T80131 whole brain .b 516 to 838 1 to 325     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 325/327
(99 %)
7 diff
(97.9 %id)
BM790039 stomach .b 633 to 1312 1 to 681       681/688
(98 %)
2 diff
(99.8 %id)
F07591 brain, total brain .b 668 to 902 1 to 235       235/235
(100 %)
0 diff
(100 %id)
BU156948 hepatocellular carcinoma, cell line, Liver .b 669 to 1698 1 to 1039       1039/1041
(99 %)
29 diff
(97.3 %id)
CU443299 epidermis .b 683 to 1397 1 to 716       716/717
(99 %)
10 diff
(98.7 %id)
CU445521 epidermis .b 687 to 1397 5 to 716       712/722
(98 %)
11 diff
(98.5 %id)
CU453547 epidermis .b 687 to 1397 5 to 716       712/722
(98 %)
11 diff
(98.5 %id)
CU455072 epidermis .b 697 to 1397 706 to 7     Submitted on the opposite strand 700/709
(98 %)
0 diff
(100 %id)
AL579232 T cells (Jurkat cell line), T cells from T cell leukemia .b 1149 to 2123 965 to 1   fully sequenced,   965/965
(100 %)
65 diff
(93.3 %id)
DB372924 placenta .b 1679 to 2174 497 to 1   tiling clone,   497/497
(100 %)
19 diff
(96.2 %id)
F03839 brain, total brain .b 1825 to 2167 343 to 1       343/343
(100 %)
0 diff
(100 %id)
R40762 whole brain .b 1846 to 2173 353 to 15   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 339/342
(99 %)
16 diff
(95.4 %id)
DB334346 stomach .b 1898 to 2167 277 to 8       270/279
(96 %)
0 diff
(100 %id)
R40319 whole brain .b 1905 to 2173 288 to 13   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 276/370
(74 %)
7 diff
(98.2 %id)
R39355 whole brain .b 2000 to 2173 188 to 13   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 176/176
(100 %)
2 diff
(98.9 %id)
BI520043 brain, medulla .c 1 to 491 1 to 491   tiling clone,   491/491
(100 %)
2 diff
(99.6 %id)
NM_001010990.1   .c 1 to 2101 1 to 2101 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 2101/2101
(100 %)
0 diff
(100 %id)
DC394816 testis .c 3 to 492 1 to 491   tiling clone,   491/491
(100 %)
5 diff
(99.0 %id)
DC302280 cerebellum .c 303 to 570 1 to 268       268/268
(100 %)
1 diff
(99.7 %id)
ES311566 frontal balding hair, skin .c 318 to 496 1 to 179       179/179
(100 %)
1 diff
(99.5 %id)
BF974426 B-cells, primary B-cells from tonsils (cell line) .c 324 to 1112 1 to 779   tiling clone,   779/968
(80 %)
14 diff
(98.6 %id)
BF974161 B-cells, primary B-cells from tonsils (cell line) .c 324 to 1145 1 to 820       820/910
(90 %)
32 diff
(96.5 %id)
BG685245 B-cells, primary B-cells from tonsils (cell line) .c 324 to 1138 1 to 821       821/829
(99 %)
19 diff
(97.8 %id)
BM790474 Ascites, stomach .c 324 to 849 1 to 526       526/526
(100 %)
2 diff
(99.7 %id)
ES308186 beard hair, skin .c 337 to 496 1 to 156       156/156
(100 %)
4 diff
(97.5 %id)
CN386586 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 353 to 613 1 to 261       261/261
(100 %)
0 diff
(100 %id)
BG898352 cartilage .c 595 to 918 86 to 408       323/340
(95 %)
9 diff
(97.4 %id)
BG898471 cartilage .c 595 to 978 81 to 464       384/401
(95 %)
15 diff
(96.3 %id)
CU452204 epidermis .c 633 to 1325 24 to 716       693/722
(95 %)
13 diff
(98.2 %id)
CU457140 epidermis .c 633 to 1325 699 to 7     Submitted on the opposite strand 693/722
(95 %)
0 diff
(100 %id)
BE825267 colon_normal .c 643 to 1012 372 to 1       372/372
(100 %)
4 diff
(99.0 %id)
ES313049 beard hair, skin .c 649 to 813 1 to 165       165/165
(100 %)
0 diff
(100 %id)
CB217033 normal endometrium, mid-secretory phase,cycle day 23, uterus .c 662 to 1322 1 to 660       660/660
(100 %)
1 diff
(99.9 %id)
BM707911 eye, RPE and Choroid .c 687 to 1210 1 to 524     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 524/524
(100 %)
0 diff
(100 %id)
BP296606   .c 710 to 1291 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CB136083 Liver .c 712 to 1255 1 to 544       544/544
(100 %)
0 diff
(100 %id)
BM791593 stomach .c 739 to 1368 1 to 630       630/630
(100 %)
0 diff
(100 %id)
BE161510 head_neck .c 758 to 872 116 to 1     Submitted on the opposite strand 116/125
(92 %)
8 diff
(93.6 %id)
FN109021 breast carcinoma .c 758 to 859 1 to 101       101/101
(100 %)
6 diff
(94.1 %id)
EC443356 Prostate .c 797 to 888 95 to 4       92/100
(92 %)
0 diff
(100 %id)
BQ331124 lung_tumor .c 814 to 1242 442 to 11       433/442
(97 %)
0 diff
(100 %id)
TI_227712362   .c 821 to 1690 950 to 86   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 865/1009
(85 %)
14 diff
(98.7 %id)
AW993548 breast_normal .c 824 to 1127 306 to 3     Submitted on the opposite strand 304/306
(99 %)
0 diff
(100 %id)
BG196342   .c 832 to 1123 340 to 50     Submitted on the opposite strand 291/340
(85 %)
1 diff
(99.8 %id)
BG013434 placenta_normal .c 852 to 1191 337 to 2       336/337
(99 %)
0 diff
(100 %id)
TI_154171269   .c 870 to 1437 80 to 650       571/906
(63 %)
17 diff
(98.2 %id)
BF845142 head_neck .c 900 to 1078 189 to 9     Submitted on the opposite strand 181/189
(95 %)
0 diff
(100 %id)
FN143189 breast carcinoma .c 901 to 985 87 to 3     Submitted on the opposite strand 85/91
(93 %)
0 diff
(100 %id)
CU453244 epidermis .c 916 to 1610 704 to 10     Submitted on the opposite strand 695/704
(98 %)
1 diff
(99.9 %id)
FN143264 breast carcinoma .c 916 to 988 72 to 1     Submitted on the opposite strand 72/82
(87 %)
1 diff
(98.8 %id)
BP317950 pericardium .c 918 to 1500 1 to 583   tiling clone,   583/583
(100 %)
0 diff
(100 %id)
BP337747 coronary artery .c 918 to 1499 1 to 582       582/582
(100 %)
0 diff
(100 %id)
F11814 brain, total brain .c 939 to 1255 1 to 317       317/317
(100 %)
0 diff
(100 %id)
ES308706 beard hair, skin .c 952 to 1164 1 to 213       213/213
(100 %)
0 diff
(100 %id)
BM699958 eye, lens .c 997 to 1247 1 to 251     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 251/251
(100 %)
0 diff
(100 %id)
BX477534   .c 1010 to 1589 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP302639   .c 1013 to 1587 1 to 575       575/575
(100 %)
0 diff
(100 %id)
TI_1948126222   .c 1016 to 1509 636 to 138       499/1290
(38 %)
19 diff
(98.6 %id)
BQ233399 epithelioid carcinoma, Pancreas .c 1017 to 1901 1 to 887       887/888
(99 %)
5 diff
(99.5 %id)
CD367079 Alveolar Macrophage, lung .c 1039 to 1690 667 to 16   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 652/653
(99 %)
0 diff
(100 %id)
BI257882 cervical carcinoma cell line, cervix .c 1051 to 1927 1 to 874       874/874
(100 %)
11 diff
(98.8 %id)
AA485473 lung .c 1053 to 1507 1 to 455       455/455
(100 %)
0 diff
(100 %id)
BF748534 breast_normal .c 1084 to 1516 437 to 2     Submitted on the opposite strand 436/437
(99 %)
3 diff
(99.4 %id)
DT220351 brain .c 1114 to 1754 1 to 641       641/641
(100 %)
0 diff
(100 %id)
FN078037 breast carcinoma .c 1121 to 1214 93 to 1     Submitted on the opposite strand 93/93
(100 %)
1 diff
(99.0 %id)
AA343620 gall bladder .c 1126 to 1366 1 to 241       241/241
(100 %)
0 diff
(100 %id)
BG621457 placenta .c 1146 to 1851 1 to 705       705/705
(100 %)
5 diff
(99.3 %id)
BM795541 stomach .c 1153 to 1726 1 to 574       574/574
(100 %)
0 diff
(100 %id)
ES311767 frontal balding hair, skin .c 1160 to 1338 1 to 178       178/178
(100 %)
1 diff
(99.5 %id)
BF195648 fibrotheoma, ovary .c 1175 to 1701 1 to 527     Submitted on the opposite strand 527/527
(100 %)
0 diff
(100 %id)
BE140627 head_neck .c 1191 to 1494 304 to 1     Submitted on the opposite strand 304/304
(100 %)
0 diff
(100 %id)
BE161371 head_neck .c 1196 to 1596 401 to 1     Submitted on the opposite strand 401/401
(100 %)
3 diff
(99.3 %id)
BE161376 head_neck .c 1196 to 1596 401 to 1     Submitted on the opposite strand 401/401
(100 %)
4 diff
(99.1 %id)
AA701658 liver and spleen .c 1202 to 2095 899 to 1       899/899
(100 %)
37 diff
(95.9 %id)
BF988267 placenta_normal .c 1211 to 1568 359 to 2       358/359
(99 %)
0 diff
(100 %id)
BM689802 eye, Retina Foveal and Macular .c 1216 to 1536 8 to 328     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 321/328
(97 %)
0 diff
(100 %id)
FN123034 breast carcinoma .c 1228 to 1319 93 to 2     Submitted on the opposite strand 92/94
(97 %)
0 diff
(100 %id)
TI_154107156   .c 1234 to 2101 961 to 102   tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 860/956
(89 %)
18 diff
(98.2 %id)
BQ338686 nervous_normal .c 1240 to 1772 533 to 1       533/564
(94 %)
7 diff
(98.8 %id)
BG190873   .c 1241 to 2083 854 to 12     Submitted on the opposite strand 843/854
(98 %)
0 diff
(100 %id)
TI_59383849   .c 1242 to 2101 105 to 984       880/935
(94 %)
46 diff
(95.1 %id)
BG197427   .c 1244 to 2081 848 to 13     Submitted on the opposite strand 836/848
(98 %)
5 diff
(99.5 %id)
CU454671 epidermis .c 1245 to 1325 6 to 86       81/90
(90 %)
6 diff
(93.4 %id)
BG201060   .c 1246 to 2081 846 to 13     Submitted on the opposite strand 834/847
(98 %)
4 diff
(99.6 %id)
BG194453   .c 1247 to 2081 847 to 13     Submitted on the opposite strand 835/847
(98 %)
1 diff
(99.9 %id)
TI_149315652   .c 1252 to 2101 930 to 89   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 842/990
(85 %)
17 diff
(98.3 %id)
N56706 placenta .c 1257 to 1571 1 to 315       315/315
(100 %)
0 diff
(100 %id)
N56718.
matches multiple genes
placenta .c 1257 to 1529 1 to 273     also hits gene ATXN7 273/273
(100 %)
0 diff
(100 %id)
TI_149303765   .c 1257 to 2101 918 to 79   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 840/993
(84 %)
17 diff
(98.3 %id)
BI010716 lung_normal .c 1268 to 1829 582 to 22       561/582
(96 %)
1 diff
(99.9 %id)
AW905699 nervous_normal .c 1272 to 1772 500 to 1       500/550
(90 %)
10 diff
(98.2 %id)
TI_149311764   .c 1279 to 2101 913 to 93   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 821/972
(84 %)
14 diff
(98.6 %id)
BM704898 eye, RPE and Choroid .c 1289 to 1826 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
BF854559 lung_normal .c 1292 to 1831 548 to 10     Submitted on the opposite strand 539/548
(98 %)
1 diff
(99.9 %id)
BI010436 lung_normal .c 1310 to 1831 529 to 13       517/531
(97 %)
0 diff
(100 %id)
BF326626 breast_normal .c 1327 to 1791 496 to 32       465/496
(93 %)
0 diff
(100 %id)
TI_154144120   .c 1329 to 2052 80 to 803       724/724
(100 %)
6 diff
(99.2 %id)
TI_154107300   .c 1334 to 2091 834 to 80   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 755/920
(82 %)
7 diff
(99.3 %id)
TI_154115933   .c 1334 to 2091 852 to 96   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 757/801
(94 %)
12 diff
(98.6 %id)
BM711040 eye, fetal eyes .c 1334 to 1524 1 to 191   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 191/191
(100 %)
1 diff
(99.5 %id)
TI_149296180   .c 1343 to 2101 837 to 82   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 756/943
(80 %)
10 diff
(99.0 %id)
AW935915 denis_drash .c 1344 to 1791 451 to 4     Submitted on the opposite strand 448/452
(99 %)
0 diff
(100 %id)
TI_149297533   .c 1344 to 2095 807 to 57   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 751/973
(77 %)
2 diff
(99.8 %id)
TI_149294595   .c 1345 to 2091 838 to 91   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 748/970
(77 %)
2 diff
(99.8 %id)
TI_227717617   .c 1350 to 2095 829 to 84   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 746/962
(77 %)
1 diff
(99.9 %id)
TI_149298599   .c 1356 to 2101 830 to 85   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 746/805
(92 %)
37 diff
(95.5 %id)
BP419559 small intestine .c 1357 to 1856 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
TI_154115915   .c 1357 to 2095 850 to 116   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 735/789
(93 %)
12 diff
(98.5 %id)
TI_149305116   .c 1375 to 2101 795 to 83   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 713/893
(79 %)
17 diff
(98.1 %id)
AI707695 aorta .c 1377 to 2101 725 to 1       725/726
(99 %)
6 diff
(99.2 %id)
BM988454 lung, Metastatic Chondrosarcoma .c 1382 to 2101 737 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 719/719
(100 %)
2 diff
(99.8 %id)
BM985115 lung .c 1382 to 2091 728 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 710/710
(100 %)
0 diff
(100 %id)
BM981705 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1382 to 2101 738 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 720/720
(100 %)
0 diff
(100 %id)
CA447062 Chondrosarcoma, Left Pubic Bone .c 1382 to 2091 727 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 709/709
(100 %)
1 diff
(99.9 %id)
CD368546 Alveolar Macrophage, lung .c 1382 to 2095 731 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 713/713
(100 %)
3 diff
(99.6 %id)
AI262845 adenocarcinoma, colon .c 1388 to 1925 538 to 1       538/538
(100 %)
0 diff
(100 %id)
TI_57149117   .c 1390 to 1953 27 to 590       564/590
(95 %)
6 diff
(99.0 %id)
BF081583 amnion_normal .c 1391 to 1660 274 to 2       273/274
(99 %)
0 diff
(100 %id)
BF083702 colon .c 1392 to 1772 381 to 1       381/384
(99 %)
9 diff
(97.7 %id)
AI590087 anaplastic oligodendroglioma, brain .c 1394 to 2101 715 to 8       708/715
(99 %)
0 diff
(100 %id)
TI_154034724   .c 1404 to 2097 767 to 84   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 684/798
(85 %)
14 diff
(98.3 %id)
BM977534 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1405 to 2101 715 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 697/697
(100 %)
0 diff
(100 %id)
TI_149290942   .c 1413 to 2101 767 to 79   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 689/690
(99 %)
1 diff
(99.9 %id)
TI_154127682   .c 1414 to 2101 776 to 96   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 681/920
(74 %)
13 diff
(98.6 %id)
BQ020563 Fibrosarcoma .c 1434 to 2101 684 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 666/667
(99 %)
2 diff
(99.8 %id)
BF439995 brain, glioblastoma (pooled) .c 1445 to 2095 651 to 1       651/651
(100 %)
0 diff
(100 %id)
BQ183411 Knee, Osteoarthritic Cartilage .c 1446 to 2101 674 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 656/668
(98 %)
0 diff
(100 %id)
BE004986 breast_normal .c 1447 to 1571 1 to 125       125/125
(100 %)
7 diff
(94.4 %id)
CA449564 Chondrosarcoma, Left Pelvis .c 1471 to 2091 639 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 621/621
(100 %)
0 diff
(100 %id)
BM666128 eye, fetal eyes .c 1498 to 2095 616 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 598/598
(100 %)
0 diff
(100 %id)
BM669914 eye, lens .c 1506 to 2101 614 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 596/596
(100 %)
0 diff
(100 %id)
BM661839 eye, Retina Foveal and Macular .c 1597 to 2101 523 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 505/505
(100 %)
0 diff
(100 %id)
BU732994 eye, RPE and Choroid .c 1649 to 2101 471 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 453/453
(100 %)
1 diff
(99.8 %id)
AA485316 lung .c 1688 to 1859 172 to 1       172/172
(100 %)
0 diff
(100 %id)
F09462 brain, total brain .c 1782 to 2097 316 to 1       316/316
(100 %)
0 diff
(100 %id)
AK302167 testis .d 1 to 1307 2 to 1314 L15R Q93R E94P R96E H97K ... tiling clone,   1314/1314
(100 %)
8 diff
(99.4 %id)
DC398172 testis .d 1 to 545 2 to 552       552/552
(100 %)
8 diff
(98.6 %id)
BG204664   .d 1133 to 1799 675 to 13     Submitted on the opposite strand 663/838
(79 %)
0 diff
(100 %id)
TI_149308917   .d 1166 to 1819 763 to 112   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 652/913
(71 %)
19 diff
(98.0 %id)
BG205740   .d 1195 to 1730 537 to 1     Submitted on the opposite strand 537/757
(70 %)
27 diff
(96.5 %id)
CB306441 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 1198 to 1819 640 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 622/622
(100 %)
0 diff
(100 %id)
CA446941 Chondrosarcoma, Left Pubic Bone .d 1198 to 1819 640 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 622/622
(100 %)
0 diff
(100 %id)
TI_149305749   .d 1200 to 1815 698 to 83   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 616/927
(66 %)
2 diff
(99.8 %id)
BQ775715 Bone, Human Chondrosarcoma Cell Line .d 1206 to 1819 632 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 614/618
(99 %)
0 diff
(100 %id)
CA417314 Chondrosarcoma Cell line .d 1207 to 1819 630 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 612/612
(100 %)
1 diff
(99.9 %id)
BU684194 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 1208 to 1819 630 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 612/612
(100 %)
0 diff
(100 %id)
CA434931 lung, Metastatic Chondrosarcoma .d 1214 to 1823 628 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 610/610
(100 %)
0 diff
(100 %id)
BG187558   .d 1242 to 1801 573 to 14     Submitted on the opposite strand 560/853
(65 %)
0 diff
(100 %id)
BQ181795 Knee, Osteoarthritic Cartilage .d 1253 to 1819 585 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 567/567
(100 %)
0 diff
(100 %id)
BM982580 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 1253 to 1813 579 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 561/561
(100 %)
0 diff
(100 %id)
BM691811 eye, human retina .d 1254 to 1809 9 to 564       556/564
(98 %)
6 diff
(99.0 %id)
EL948768 eyeball .d 1255 to 1820 11 to 577   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 567/577
(98 %)
6 diff
(99.0 %id)
BF751873 breast_normal .d 1271 to 1601 335 to 7     Submitted on the opposite strand 329/335
(98 %)
0 diff
(100 %id)
BF061641 fibrotheoma, ovary .d 1275 to 1819 545 to 1       545/545
(100 %)
0 diff
(100 %id)
CK825942 Pancreas, Purified pancreatic islet .d 1275 to 1815 552 to 12   AAA Submitted on the opposite strand 541/541
(100 %)
0 diff
(100 %id)
BE046206 follicular carcinoma, thyroid .d 1280 to 1577 298 to 1       298/298
(100 %)
0 diff
(100 %id)
AI675465 Prostate .d 1282 to 1813 532 to 1       532/532
(100 %)
0 diff
(100 %id)
AW088400 ovary, tumor, 5 pooled (see description) .d 1290 to 1577 288 to 1       288/288
(100 %)
0 diff
(100 %id)
BQ363976 stomach .d 1295 to 1444 153 to 8       146/156
(93 %)
0 diff
(100 %id)
AW664427 2 pooled high-grade transitional celltumors, genitourinary tract .d 1308 to 1577 270 to 1       270/270
(100 %)
0 diff
(100 %id)
AW007260 adenocarcinoma, Pancreas .d 1309 to 1577 269 to 1       269/269
(100 %)
0 diff
(100 %id)
BE815052 breast_normal .d 1310 to 1447 144 to 5       140/144
(97 %)
0 diff
(100 %id)
FN149935 breast carcinoma .d 1312 to 1409 95 to 1     Submitted on the opposite strand 95/95
(100 %)
2 diff
(97.9 %id)
BU736855 eye, RPE and Choroid .d 1312 to 1819 526 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 508/508
(100 %)
0 diff
(100 %id)
EB362013 eye, lens .d 1315 to 1802 488 to 1       488/488
(100 %)
1 diff
(99.8 %id)
AI097015 heart .d 1317 to 1813 497 to 1       497/497
(100 %)
0 diff
(100 %id)
DC426783 testis .d 1317 to 1819 503 to 1       503/503
(100 %)
0 diff
(100 %id)
TI_151758813   .d 1326 to 1813 586 to 99   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 488/874
(55 %)
2 diff
(99.8 %id)
AW191971 adenocarcinoma, Pancreas .d 1336 to 1577 242 to 1       242/242
(100 %)
0 diff
(100 %id)
BU734342 eye, RPE and Choroid .d 1339 to 1819 499 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 481/481
(100 %)
0 diff
(100 %id)
BM703571 eye, human retina .d 1354 to 1819 1 to 466   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 466/466
(100 %)
0 diff
(100 %id)
TI_154191311   .d 1357 to 1813 40 to 494   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 455/455
(100 %)
1 diff
(99.8 %id)
DB552823 hippocampus .d 1359 to 1819 1 to 461     Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
AI564273 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1367 to 1577 211 to 1       211/211
(100 %)
0 diff
(100 %id)
AI922032 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1367 to 1577 211 to 1       211/211
(100 %)
0 diff
(100 %id)
AA578570 lung, lung tumor .d 1369 to 1577 209 to 1       209/209
(100 %)
0 diff
(100 %id)
AI369436 anaplastic oligodendroglioma, brain .d 1369 to 1819 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AW338361 adenocarcinoma, Pancreas .d 1374 to 1577 204 to 1       204/204
(100 %)
0 diff
(100 %id)
AW511403 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1375 to 1577 203 to 1       203/203
(100 %)
0 diff
(100 %id)
CR742206 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1376 to 1813 452 to 15   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 438/438
(100 %)
0 diff
(100 %id)
BE677071 dorsal root ganglia .d 1379 to 1577 199 to 1       199/199
(100 %)
0 diff
(100 %id)
AW189254 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1382 to 1577 196 to 1       196/196
(100 %)
0 diff
(100 %id)
BM144363 leukopheresis .d 1385 to 1819 452 to 17       436/452
(96 %)
0 diff
(100 %id)
DB513527 testis .d 1389 to 1819 1 to 431     Submitted on the opposite strand 431/431
(100 %)
5 diff
(98.9 %id)
AA701584 liver and spleen .d 1392 to 1813 422 to 1       422/422
(100 %)
0 diff
(100 %id)
AI217433 pooled .d 1396 to 1813 432 to 15   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 418/418
(100 %)
0 diff
(100 %id)
AI312110 lung .d 1398 to 1818 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AW262698 brain, three pooled meningiomas .d 1398 to 1577 180 to 1       180/180
(100 %)
0 diff
(100 %id)
AW194163 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1403 to 1577 175 to 1       175/175
(100 %)
0 diff
(100 %id)
CA435725 lung, Metastatic Chondrosarcoma .d 1404 to 1815 428 to 17   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 412/412
(100 %)
0 diff
(100 %id)
CR737635 ovary, tumor, 5 pooled (see description) .d 1405 to 1819 429 to 15   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 415/415
(100 %)
0 diff
(100 %id)
AA513657 breast .d 1407 to 1812 406 to 1       406/406
(100 %)
0 diff
(100 %id)
BJ994347 hepatoblastoma .d 1408 to 1789 382 to 1       382/382
(100 %)
0 diff
(100 %id)
AI345980 adenocarcinoma, colon .d 1410 to 1819 420 to 11   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 410/410
(100 %)
0 diff
(100 %id)
AI624874 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1414 to 1577 164 to 1       164/164
(100 %)
0 diff
(100 %id)
AA643141 epithelium (cell line), Prostate .d 1418 to 1577 160 to 1       160/160
(100 %)
0 diff
(100 %id)
AA988993 carcinoid, lung .d 1418 to 1818 401 to 1       401/401
(100 %)
0 diff
(100 %id)
BF058149 fibrotheoma, ovary .d 1422 to 1815 394 to 1       394/394
(100 %)
0 diff
(100 %id)
BQ329522 lung_normal .d 1424 to 1541 118 to 1       118/125
(94 %)
1 diff
(99.2 %id)
AI752646 Bone, Hip .d 1451 to 1788 345 to 8       338/345
(97 %)
0 diff
(100 %id)
AI091768 heart .d 1452 to 1813 362 to 1       362/362
(100 %)
0 diff
(100 %id)
FN068718 breast carcinoma .d 1464 to 1535 72 to 2     Submitted on the opposite strand 71/73
(97 %)
0 diff
(100 %id)
AI420806 Prostate .d 1468 to 1813 357 to 12   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 346/346
(100 %)
0 diff
(100 %id)
AI718717 aorta .d 1494 to 1817 324 to 1       324/324
(100 %)
0 diff
(100 %id)
AA568843 colon, colon tumor RER+ .d 1509 to 1819 322 to 12   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 311/311
(100 %)
0 diff
(100 %id)
FN111534 breast carcinoma .d 1513 to 1604 92 to 1     Submitted on the opposite strand 92/92
(100 %)
0 diff
(100 %id)
AI919137 pooled germ cell tumors .d 1515 to 1811 297 to 1       297/297
(100 %)
0 diff
(100 %id)
FN153879 breast carcinoma .d 1516 to 1610 94 to 1     Submitted on the opposite strand 94/94
(100 %)
2 diff
(97.9 %id)
AW370967 breast .d 1523 to 1799 276 to 2       275/287
(95 %)
0 diff
(100 %id)
AW370969 breast .d 1523 to 1800 277 to 1       277/288
(96 %)
6 diff
(98.0 %id)
AW370970 breast .d 1523 to 1795 273 to 3       271/284
(95 %)
0 diff
(100 %id)
AW371001 breast .d 1523 to 1739 216 to 1       216/238
(90 %)
3 diff
(98.8 %id)
FN059508 breast carcinoma .d 1532 to 1625 94 to 1     Submitted on the opposite strand 94/94
(100 %)
0 diff
(100 %id)
BM817980 stomach .d 1547 to 1820 1 to 274   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 274/274
(100 %)
0 diff
(100 %id)
AI419155 brain, glioblastoma (pooled) .d 1569 to 1819 251 to 1       251/251
(100 %)
0 diff
(100 %id)
AI474455 Prostate .d 1569 to 1819 251 to 1       251/251
(100 %)
0 diff
(100 %id)
AA350128 brain .d 1575 to 1819 245 to 1       245/245
(100 %)
0 diff
(100 %id)
FN049285 breast carcinoma .d 1579 to 1678 1 to 100       100/101
(99 %)
1 diff
(99.1 %id)
FN074694 breast carcinoma .d 1579 to 1677 1 to 96       96/97
(98 %)
3 diff
(97.0 %id)
FN096577 breast carcinoma .d 1594 to 1706 116 to 1     Submitted on the opposite strand 116/116
(100 %)
3 diff
(97.5 %id)
AA513258 Prostate .d 1595 to 1819 234 to 10       225/234
(96 %)
0 diff
(100 %id)
AA657922   .d 1595 to 1819 245 to 21   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 225/225
(100 %)
0 diff
(100 %id)
AW150623 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1595 to 1819 225 to 1       225/225
(100 %)
0 diff
(100 %id)
BM988821 lung, Lung Focal Fibrosis .d 1598 to 1819 240 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 222/222
(100 %)
0 diff
(100 %id)
AJ711190 heart .d 1608 to 1817 233 to 24   AAA Submitted on the opposite strand 210/210
(100 %)
1 diff
(99.6 %id)
AA228728   .d 1667 to 1794 128 to 1       128/128
(100 %)
0 diff
(100 %id)
GD160120   .d 1672 to 1819 1 to 150   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 150/150
(100 %)
4 diff
(97.4 %id)
FN052995 breast carcinoma .d 1676 to 1807 1 to 132       132/132
(100 %)
0 diff
(100 %id)
CD516159 White Matter .d 1813 to 2450 1 to 649   tiling clone,   649/1045
(62 %)
31 diff
(97.1 %id)
AI458327 carcinoid, lung .d 1926 to 2344 1 to 419   tiling clone, Submitted on the opposite strand 419/419
(100 %)
2 diff
(99.6 %id)
AA363353 ovary .d 2356 to 2651 1 to 296   tiling clone,   296/296
(100 %)
0 diff
(100 %id)
DQ837586   .e 1 to 1425 1 to 1425 exact tiling clone,   1425/1425
(100 %)
0 diff
(100 %id)
CX865785 embryonic stem .e 7 to 588 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CX865724 embryonic stem .e 1194 to 1701 548 to 41   tiling clone, AAA   508/515
(98 %)
0 diff
(100 %id)
DB448416 testis .f 1 to 421 1 to 423   tiling clone,   423/423
(100 %)
10 diff
(97.7 %id)
BU947315 insulinoma, Pancreas .f 98 to 641 1 to 544   tiling clone,   544/544
(100 %)
4 diff
(99.3 %id)
AI200700 placenta .f 557 to 1113 555 to 1       555/560
(99 %)
3 diff
(99.5 %id)
AA877722 colon, colon tumor RER+ .f 564 to 1114 551 to 1   tiling clone,   551/551
(100 %)
4 diff
(99.3 %id)
AI189487 placenta .f 576 to 1113 549 to 12   AAA   538/538
(100 %)
0 diff
(100 %id)
AI184818 placenta .f 582 to 1113 532 to 1       532/532
(100 %)
5 diff
(99.1 %id)
BU786104 insulinoma, Pancreas .f 656 to 1113 476 to 19   AAA   458/458
(100 %)
0 diff
(100 %id)
DA223879 brain .f 1097 to 1696 2 to 599   tiling clone, capped   598/598
(100 %)
4 diff
(99.4 %id)
BF174238 blood .f 1406 to 1624 1 to 221   tiling clone,   221/227
(97 %)
15 diff
(93.4 %id)
BC009739 Brain, glioblastoma .g 1 to 1388 1 to 1388 L4R tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1388/1388
(100 %)
1 diff
(100.0 %id)
TI_1948100594   .g 98 to 773 140 to 819   fully sequenced,   680/819
(83 %)
29 diff
(96.5 %id)
CV028084 mixed .g 99 to 698 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
TI_1948100595   .g 496 to 796 429 to 129   fully sequenced,   301/429
(70 %)
0 diff
(100 %id)
BG828243 muscle, rhabdomyosarcoma .h 1 to 838 1 to 843 L216F P217A tiling clone,   843/851
(99 %)
14 diff
(98.4 %id)
BE298909 muscle, rhabdomyosarcoma .h 21 to 537 1 to 519       519/519
(100 %)
5 diff
(99.1 %id)
AF217990   .i 1 to 2199 1 to 2199 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 2199/2199
(100 %)
0 diff
(100 %id)
BG924549 cartilage .i 280 to 836 89 to 646       558/571
(97 %)
6 diff
(99.0 %id)
BF216906 brain, glioblastoma .j 223 to 613 240 to 624 R22G D23M L24W E25S L26* tiling clone,   629/652
(96 %)
42 diff
(93.6 %id)
AK304800 uterus .k 1 to 1125 1 to 1125 L4R tiling clone,   1125/1125
(100 %)
1 diff
(100.0 %id)
AW078924 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .k 423 to 752 331 to 1       331/334
(99 %)
2 diff
(99.5 %id)
CV420580 lung_tumor .k 432 to 927 48 to 542       495/542
(91 %)
6 diff
(98.9 %id)
DR979570 placenta .k 565 to 762 1 to 197     Submitted on the opposite strand 197/197
(100 %)
5 diff
(97.5 %id)
CD703226 normal nasopharynx .k 613 to 1147 40 to 574   tiling clone,   535/574
(93 %)
6 diff
(99.0 %id)
BG430543 Kidney .l 1 to 559 1 to 561 A101R F102L V103C P104S P105T ... tiling clone,   561/774
(72 %)
16 diff
(98.0 %id)
DA130497 alzheimer cortex .m 1 to 562 2 to 563 exact tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
BF174410 blood .n 1 to 459 1 to 459 exact tiling clone,   459/459
(100 %)
2 diff
(99.6 %id)
DA177619 amygdala .o 1 to 570 2 to 571 C86G tiling clone, capped   570/570
(100 %)
2 diff
(99.7 %id)
DA514854 brain .o 1 to 563 2 to 565 D23X E25G L26A S27E G28W ... tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
BF921722 nervous_tumor .o 410 to 739 347 to 9   tiling clone, Submitted on the opposite strand 339/347
(97 %)
23 diff
(93.4 %id)
N76205 liver and spleen .o 485 to 643 1 to 158   tiling clone,   158/161
(98 %)
2 diff
(98.8 %id)
DW430178 Liver .o 594 to 965 17 to 390   tiling clone,   374/390
(95 %)
6 diff
(98.5 %id)
BQ325080 colon_ins .o 638 to 1066 440 to 7       434/440
(98 %)
0 diff
(100 %id)
CN271034 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 638 to 1252 1 to 615   tiling clone,   615/615
(100 %)
3 diff
(99.6 %id)
CN270948 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 649 to 1135 1 to 487       487/487
(100 %)
5 diff
(99.0 %id)
DW427566 Liver .o 734 to 999 14 to 278       265/278
(95 %)
6 diff
(97.9 %id)
DA376763 thalamus .o 764 to 1317 2 to 555   tiling clone, capped   554/554
(100 %)
0 diff
(100 %id)
BX471190   .o 818 to 1202 1 to 385       385/386
(99 %)
4 diff
(99.0 %id)
BM829289 Ascites, stomach .o 1188 to 1509 1 to 322   tiling clone,   322/322
(100 %)
0 diff
(100 %id)
AI479304 Kidney .o 1402 to 1962 561 to 1       561/561
(100 %)
0 diff
(100 %id)
BU752932 placenta .o 1406 to 1962 574 to 18   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 557/557
(100 %)
1 diff
(99.9 %id)
AW473606 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .o 1432 to 1963 532 to 1   tiling clone,   532/532
(100 %)
0 diff
(100 %id)
AA604842   .o 1508 to 1873 1 to 366       366/366
(100 %)
1 diff
(99.8 %id)
AI580326 Kidney .o 1545 to 1962 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AA973268 2 pooled tumors (clear cell type), Kidney .o 1568 to 1965 399 to 3   tiling clone,   397/399
(99 %)
0 diff
(100 %id)
BX486751   .p 1 to 452 42 to 493   tiling clone,   452/493
(91 %)
6 diff
(98.8 %id)
AL599956   .p 263 to 773 1 to 509 R49H tiling clone,   509/509
(100 %)
4 diff
(99.3 %id)
BX496195 Liver .q 1 to 567 5 to 571 R2K L5R tiling clone,   571/571
(100 %)
5 diff
(99.2 %id)
BX506573 Liver .r 1 to 677 1 to 676   tiling clone,   676/676
(100 %)
30 diff
(95.6 %id)
FN097547 breast carcinoma .r 391 to 490 1 to 101       101/101
(100 %)
1 diff
(99.1 %id)
AW178999 stomach .r 455 to 712 1 to 258       258/258
(100 %)
1 diff
(99.7 %id)
BF370278 prostate_normal .r 482 to 819 336 to 1       336/355
(94 %)
5 diff
(98.6 %id)
BX497759 Liver .r 640 to 1027 1 to 388   tiling clone,   388/388
(100 %)
1 diff
(99.8 %id)
BG485395 lung .r 856 to 1290 1 to 436 H75Q N76Q G110W tiling clone,   436/436
(100 %)
5 diff
(98.9 %id)
BX498444 Liver .s-u 1 to 649 1 to 647 S13Q N14I I15Y H16T N17T ... tiling clone,   647/647
(100 %)
2 diff
(99.7 %id)
BX498443 Liver .s-u 60 to 431 1 to 372   tiling clone,   372/372
(100 %)
21 diff
(94.4 %id)
DA958760 Spleen .s-u 286 to 833 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
AA352726   .s-u 343 to 626 1 to 282       282/282
(100 %)
2 diff
(99.3 %id)
BU072189 Pancreas, Purified pancreatic islet .s-u 411 to 1072 11 to 672   tiling clone, fully sequenced,   662/672
(98 %)
6 diff
(99.2 %id)
CB268671 adipose .s-u 464 to 873 1 to 410       410/410
(100 %)
7 diff
(98.3 %id)
DW416283 Liver .s-u 605 to 897 17 to 309       293/309
(94 %)
6 diff
(98.1 %id)
DW430402 Liver .s-u 605 to 860 17 to 272       256/272
(94 %)
6 diff
(97.8 %id)
AW407567 lymph .s-u 654 to 877 8 to 232       225/232
(96 %)
6 diff
(97.5 %id)
TI_154147360   .s-u 654 to 1068 82 to 496       415/415
(100 %)
10 diff
(97.6 %id)
AA917683 Kidney .s-u 701 to 1097 397 to 1       397/397
(100 %)
2 diff
(99.5 %id)
W95976 heart .s-u 702 to 1097 1 to 399   fully sequenced, AAA   399/399
(100 %)
3 diff
(99.3 %id)
BU076173 Pancreas, Purified pancreatic islet .s-u 742 to 1098 358 to 1   fully sequenced,   358/358
(100 %)
4 diff
(98.9 %id)
AA199798   .s-u 760 to 1172 1 to 426   tiling clone,   426/428
(99 %)
22 diff
(94.9 %id)
DA941090 Spleen .s-u 796 to 1365 2 to 570   tiling clone, capped   569/569
(100 %)
3 diff
(99.5 %id)
W95841 heart .s-u 817 to 1097 281 to 1   fully sequenced,   281/281
(100 %)
1 diff
(99.7 %id)
DB333188 Spleen .s-u 2177 to 2708 534 to 1   tiling clone,   534/534
(100 %)
2 diff
(99.7 %id)
AA199629   .s-u 2264 to 2708 448 to 2   tiling clone,   447/449
(99 %)
0 diff
(100 %id)
DR762745 embryonic stem .t-u 1 to 602 10 to 611 exact tiling clone,   602/611
(98 %)
0 diff
(100 %id)
BF170388 blood .t-u 136 to 489 1 to 354 I29V     354/354
(100 %)
5 diff
(98.6 %id)
BC015447 Kidney, hypernephroma .t-u 330 to 1026 1 to 697   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 697/697
(100 %)
0 diff
(100 %id)
BG170810 hypernephroma, cell line, Kidney .t-u 330 to 1026 1 to 690   available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 690/690
(100 %)
12 diff
(98.3 %id)
BE061271 breast .t-u 834 to 1284 17 to 465   tiling clone,   449/465
(96 %)
6 diff
(98.8 %id)
BE140634 head_neck .t-u 836 to 1391 1 to 559   tiling clone,   559/559
(100 %)
3 diff
(99.5 %id)
DB120555 thymus .t-u 1348 to 1903 2 to 558   tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
DA638668 Liver .u 1 to 553 2 to 559   tiling clone, capped   558/558
(100 %)
5 diff
(99.2 %id)
FN111713 breast carcinoma .u 139 to 246 107 to 1   tiling clone, Submitted on the opposite strand 107/107
(100 %)
1 diff
(99.1 %id)
AW845229 colon .u 434 to 808 376 to 1   tiling clone,   376/377
(99 %)
6 diff
(98.5 %id)
W05828 lung .u 455 to 749 1 to 302       302/327
(92 %)
13 diff
(96.1 %id)
AW178886 stomach .u 474 to 809 8 to 340       333/340
(97 %)
8 diff
(97.7 %id)
BE773288 prostate_tumor .u 481 to 942 472 to 8   tiling clone,   465/472
(98 %)
6 diff
(98.8 %id)
N77871 lung .u 1007 to 1416 411 to 1 exact tiling clone,   411/411
(100 %)
1 diff
(99.8 %id)
DB321261 Liver .u 1228 to 1410 187 to 3       185/187
(98 %)
0 diff
(100 %id)
EB387984 eye, optic nerve .va-u 1 to 781 1 to 781 exact tiling clone,   781/781
(100 %)
0 diff
(100 %id)
BP310564 brain .vb-u 1 to 583 1 to 583 exact tiling clone,   583/583
(100 %)
2 diff
(99.7 %id)
DB216165 trachea .vb-u 32 to 574 2 to 545 exact tiling clone, capped   544/544
(100 %)
2 diff
(99.7 %id)
DA955222 Spleen .vc-u 1 to 573 2 to 574 exact tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
CA390143 eye, RPE/choroid .vd-u 1 to 573 1 to 573 exact tiling clone,   573/573
(100 %)
0 diff
(100 %id)
AW135359   .vd-u 24 to 556 550 to 18 exact AAA   533/533
(100 %)
0 diff
(100 %id)
ES311030 scalp interfollicular dermis, skin .vd-u 44 to 468 1 to 425 V10X     425/425
(100 %)
6 diff
(98.6 %id)
BP243522 Liver Gene HERPUD1, variant not shown         This clone was ignored    
TI_154139434   Gene HERPUD1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s-u, .t-u, .u, .va-u, .vb-u, .vc-u, .vd-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI